220 related articles for article (PubMed ID: 35972825)
1. High-throughput CRISPRi and CRISPRa technologies in 3D genome regulation for neuropsychiatric diseases.
Jones IR; Ren X; Shen Y
Hum Mol Genet; 2022 Oct; 31(R1):R47-R53. PubMed ID: 35972825
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-based functional genomics for neurological disease.
Kampmann M
Nat Rev Neurol; 2020 Sep; 16(9):465-480. PubMed ID: 32641861
[TBL] [Abstract][Full Text] [Related]
3. CRISPRi and CRISPRa Screens in Mammalian Cells for Precision Biology and Medicine.
Kampmann M
ACS Chem Biol; 2018 Feb; 13(2):406-416. PubMed ID: 29035510
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi.
Bendixen L; Jensen TI; Bak RO
Mol Ther; 2023 Jul; 31(7):1920-1937. PubMed ID: 36964659
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-based methods for high-throughput annotation of regulatory DNA.
Klann TS; Black JB; Gersbach CA
Curr Opin Biotechnol; 2018 Aug; 52():32-41. PubMed ID: 29500989
[TBL] [Abstract][Full Text] [Related]
6. Quantification of Genome Editing and Transcriptional Control Capabilities Reveals Hierarchies among Diverse CRISPR/Cas Systems in Human Cells.
Escobar M; Li J; Patel A; Liu S; Xu Q; Hilton IB
ACS Synth Biol; 2022 Oct; 11(10):3239-3250. PubMed ID: 36162812
[TBL] [Abstract][Full Text] [Related]
7. Targeted Modulation of Chicken Genes In Vitro Using CRISPRa and CRISPRi Toolkit.
Chapman B; Han JH; Lee HJ; Ruud I; Kim TH
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107664
[TBL] [Abstract][Full Text] [Related]
8. Higher-order combinatorial chromatin perturbations by engineered CRISPR-Cas12a for functional genomics.
Hsiung CC; Wilson CM; Sambold NA; Dai R; Chen Q; Misiukiewicz S; Arab A; Teyssier N; O'Loughlin T; Cofsky JC; Shi J; Gilbert LA
bioRxiv; 2024 Feb; ():. PubMed ID: 37781594
[TBL] [Abstract][Full Text] [Related]
9. Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation.
Dominguez AA; Lim WA; Qi LS
Nat Rev Mol Cell Biol; 2016 Jan; 17(1):5-15. PubMed ID: 26670017
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
Zhang Y; Sastre D; Wang F
Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Based Approaches for the High-Throughput Characterization of Long Non-Coding RNAs.
Hazan J; Bester AC
Noncoding RNA; 2021 Dec; 7(4):. PubMed ID: 34940760
[TBL] [Abstract][Full Text] [Related]
12. Identifying essential long non-coding RNAs in cancer using CRISPRi-based dropout screens.
Bril O; Schwarzmueller LJ; Moreno LF; Vermeulen L; Léveillé N
STAR Protoc; 2023 Dec; 4(4):102588. PubMed ID: 37773752
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Based Approaches for Gene Regulation in Non-Model Bacteria.
Call SN; Andrews LB
Front Genome Ed; 2022; 4():892304. PubMed ID: 35813973
[TBL] [Abstract][Full Text] [Related]
14. Decoding the noncoding genome via large-scale CRISPR screens.
Shukla A; Huangfu D
Curr Opin Genet Dev; 2018 Oct; 52():70-76. PubMed ID: 29913329
[TBL] [Abstract][Full Text] [Related]
15. A versatile, high-efficiency platform for CRISPR-based gene activation.
Heidersbach AJ; Dorighi KM; Gomez JA; Jacobi AM; Haley B
Nat Commun; 2023 Feb; 14(1):902. PubMed ID: 36804928
[TBL] [Abstract][Full Text] [Related]
16. Functional genomics in stem cell models: considerations and applications.
Shevade K; Peddada S; Mader K; Przybyla L
Front Cell Dev Biol; 2023; 11():1236553. PubMed ID: 37554308
[TBL] [Abstract][Full Text] [Related]
17. Reversible Gene Expression Control in Yersinia pestis by Using an Optimized CRISPR Interference System.
Wang T; Wang M; Zhang Q; Cao S; Li X; Qi Z; Tan Y; You Y; Bi Y; Song Y; Yang R; Du Z
Appl Environ Microbiol; 2019 Jun; 85(12):. PubMed ID: 30979834
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/dCas9-Mediated Gene Silencing in Two Plant Fungal Pathogens.
Zhang YM; Zheng L; Xie K
mSphere; 2023 Feb; 8(1):e0059422. PubMed ID: 36655998
[TBL] [Abstract][Full Text] [Related]
19. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.
Cho S; Shin J; Cho BK
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180
[TBL] [Abstract][Full Text] [Related]
20. High-throughput PRIME-editing screens identify functional DNA variants in the human genome.
Ren X; Yang H; Nierenberg JL; Sun Y; Chen J; Beaman C; Pham T; Nobuhara M; Takagi MA; Narayan V; Li Y; Ziv E; Shen Y
Mol Cell; 2023 Dec; 83(24):4633-4645.e9. PubMed ID: 38134886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
